HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection.
Fanales-Belasio E, Moretti S, Fiorelli V, Tripiciano A, Pavone Cossut MR, Scoglio A, Collacchi B, Nappi F, Macchia I, Bellino S, Francavilla V, Caputo A, Barillari G, Magnani M, Laguardia ME, Cafaro A, Titti F, Monini P, Ensoli F, Ensoli B.
Fanales-Belasio E, et al. Among authors: caputo a.
J Immunol. 2009 Mar 1;182(5):2888-97. doi: 10.4049/jimmunol.0711406.
J Immunol. 2009.
PMID: 19234184